Medicenna Therapeutics Corp.
MDNA.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -42.38% | 37.79% | 26.54% | 18.61% | 16.40% |
| Total Receivables | -1.33% | 118.12% | 224.97% | 386.30% | 38.11% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -15.22% | -35.33% | -48.55% | -54.46% | 4.69% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -40.28% | 39.12% | 26.59% | 18.21% | 16.59% |
|
|
|||||
| Total Current Assets | -40.28% | 39.12% | 26.59% | 18.21% | 16.59% |
| Net Property, Plant & Equipment | 407.80% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -8.71% | -14.01% | -16.17% | -8.26% | -11.26% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -39.91% | 39.74% | 27.17% | 18.85% | 16.62% |
|
|
|||||
| Total Accounts Payable | -9.50% | 22.93% | -57.14% | -46.12% | 5.76% |
| Total Accrued Expenses | 171.79% | 100.19% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 661.39% |
| Total Other Current Liabilities | -- | -- | -- | -- | 661.39% |
| Total Current Liabilities | -69.70% | 45.93% | -37.20% | -22.33% | 215.37% |
|
|
|||||
| Total Current Liabilities | -69.70% | 45.93% | -37.20% | -22.33% | 215.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -59.76% | -- | 1,516.94% | -- |
| Total Liabilities | -46.13% | -37.25% | 192.59% | 199.45% | 215.37% |
|
|
|||||
| Common Stock & APIC | 12.33% | 7.62% | 4.90% | 12.32% | 7.58% |
| Retained Earnings | -12.29% | -4.66% | -18.46% | -30.64% | -27.03% |
| Treasury Stock & Other | -99.64% | 48,770.00% | 22,546.20% | 32,643.24% | 25,755.56% |
| Total Common Equity | -35.79% | 246.55% | -14.02% | -14.33% | -17.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.79% | 246.55% | -14.02% | -14.33% | -17.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.79% | 246.55% | -14.02% | -14.33% | -17.70% |
|
|
|||||